<DOC>
	<DOCNO>NCT01716013</DOCNO>
	<brief_summary>To demonstrate BondEase™ conventional wound closure device ( CWCD ) term cosmesis ( appearance ) repair wound device use closure surgical traumatic wound . To demonstrate safety BondEase™ .</brief_summary>
	<brief_title>Safety Efficacy Study BondEase Treat Traumatic Lacerations Surgical Incisions</brief_title>
	<detailed_description>This two-phase , multi-center , prospective , randomize , parallel-group study , total 153 subject ( 102 BondEase™ group 51 CWCD group ) traumatic laceration incision enrol . Overall , eligible subject randomize pre-defined 2:1 ratio BondEase™ skin adhesive CWCD . In Part 1 study 30 subject randomize 2:1 ratio ( BondEase™ : CWCD ) . This part study design assess feasibility validate use device . Pediatric subject young age 18 include part trial . The result 30 subject compile submit FDA review approval prior proceed Part 2 . Part 2 study initiate FDA indicates acceptable begin . In Part 2 study total 123 subject randomize , 82 subject randomize BondEase™ group 41 subject CWCD group . This result 102 subject BondEase™ group 51 subject CWCD group across part trial .</detailed_description>
	<mesh_term>Lacerations</mesh_term>
	<criteria>1 . Male female subject least 1 year age ( Part 2 ) least 18 year age ( Part 1 Part 2 ) . 2 . Has wound require surgical repair , use tissue adhesive appropriate 3 . Is good general health 4 . Subject guardian understands willing sign inform consent prior study entry agree available Day 10 , Day 28 , Day 90 ( Part 1/pilot phase ) followup visit 1 . Significant multiple trauma 2 . Known peripheral vascular disease 3 . Known diabetes mellitus type 1 type 2 4 . Known blood clot disorder 5 . Patient family history keloid formation hypertrophy 6 . Known HIV seropositivity immunocompromised 7 . Been treat investigational drug medical device past 30 day 8 . A hypersensitivity contraindication component BondEase™ 9 . Known preoperative systemic local infection 10 . Any disease condition might interfere wound heal process 11 . The wound treat test device may follow characteristic : A `` burst '' stellate laceration Heavily contaminate ( Contaminated Wound : wound grossly contaminate foreign material require extensive cleansing . Human animal bite Decubitus etiology Evidence active infection gangrene On mucosal surface across mucocutaneous junction ( e.g. , oral cavity , lip ) On area may regularly expose body fluid dense natural hair , ( e.g. , scalp ) Under tension joint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>